GALNTL5
Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5
Also known as: GalNAc-T5L, GALNT15, GLTL5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z4T8
- Gene
- GALNTL5
- Ensembl
- ENSG00000106648
- Chromosome
- 7
- Canonical length
- 443 aa
- Protein class
- Disease related genes, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable metal ion binding activity and transferase activity. Involved in spermatid development. Predicted to be located in late endosome membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
443 residues, UniProt reviewed canonical sequence.
>Q7Z4T8|GALNTL5
1 MRNAIIQGLF YGSLTFGIWT ALLFIYLHHN HVSSWQKKSQ EPLSAWSPGK KVHQQIIYGS
61 EQIPKPHVIV KRTDEDKAKS MLGTDFNHTN PELHKELLKY GFNVIISRSL GIEREVPDTR
121 SKMCLQKHYP ARLPTASIVI CFYNEECNAL FQTMSSVTNL TPHYFLEEII LVDDMSKVDD
181 LKEKLDYHLE TFRGKVKIIR NKKREGLIRA RLIGASHASG DVLVFLDSHC EVNRVWLEPL
241 LHAIAKDPKM VVCPLIDVID DRTLEYKPSP LVRGTFDWNL QFKWDNVFSY EMDGPEGSTK
301 PIRSPAMSGG IFAIRRHYFN EIGQYDKDMD FWGRENLELS LRIWMCGGQL FIIPCSRVGH
361 ISKKQTGKPS TIISAMTHNY LRLVHVWLDE YKEQFFLRKP GLKYVTYGNI RERVELRKRL
421 GCKSFQWYLD NVFPELEASV NSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALNTL5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- testis: 11 nTPM
- cerebral cortex: 1.6 nTPM
- amygdala: 0.9 nTPM
- hippocampal formation: 0.7 nTPM
- basal ganglia: 0.5 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- late spermatids: 876 nCPM
- early spermatids: 659 nCPM
- late primary spermatocytes: 214 nCPM
- tuft cells: 12 nCPM
- epicardial cells: 2.3 nCPM
- retinal bipolar cells: 2.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.5 nTPM
- white matter: 0.5 nTPM
- basal ganglia: 0.2 nTPM
- amygdala: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- cerebellum: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GALNTL5.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 91 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.79
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALNTL5 as an antibody target. Whether an autoantibody or antibody against GALNTL5 could matter depends on whether native GALNTL5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALNTL5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GALNTL5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...